All volunteers inoculated with the vaccine against the novel coronavirus developed by the Vector State Research Center of Virology and Biotechnology are in good health, no side effects have been registered. The clinical trials are scheduled to be completed in September, the press service of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing reported on Friday, APA reports citing TASS.
"All inoculated volunteers are feeling well. To date, the first vaccination was administered to 57 volunteers, while 43 received placebo. Six volunteers noted soreness at the injection site. The soreness was insignificant and of a short-term nature (1-2 days). No side effects were observed among the volunteers," the statement reads.